It then ended up in someone’s yard as a piece of art for 10 years before it somehow made ... Fred now refers to it as the ‘Beat Cancer Bus’. In 2023 he was diagnosed with bladder cancer, and he says ...

Advanced Sequencing and Targeted Therapy Strategies in Renal Cell Carcinoma: How Can We Help More Patients Not at the Expense of Toxicity? Yu-Wei Chen, MD, MS Yu-Wei Chen discussed the evolving ...

A low white blood cell count is called leukopenia. A high white blood cell count is usually a sign of inflammation or infection, but it can be due to a blood-related cancer like leukemia or lymphoma.

In some cases, though, it’s important to differentiate between prostate issues and overactive bladder. Benign prostatic hyperplasia (BPH)—an enlarged prostate that isn’t caused by cancer—affects about ...

When Tyler resident Shana Yeatts was diagnosed with bladder cancer in 2023, she was not in the typical age group and didn't have any of the underlying risk factors commonly associated with the ...

The exact causes of overactive bladder (OAB) are unclear. However, risk factors for OAB include having an enlarged prostate, obesity, older age, smoking, and more. The bladder is an organ that ...

In advanced bladder cancer, the tumor’s abnormal cells grow out of control and metastasize beyond the bladder. Pain is common, so understanding what pain management options are available can ...

The European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 version 3.0 was used to measure QoL. This 30-item questionnaire is validated for use in patients with cancer, including ...

It follows Marelize Horn as she prepares to become an au pair in the Netherlands and her mother, Heidi Horn, as she handles a cancer diagnosis. The story unfolds against the backdrop of WIKA ...

Depleting the gut microbiota markedly reduced the incidence and severity of BBN-induced bladder cancer in the mice. We were able to link this result to reduced levels of N-butyl-N-(3-carboxypropyl ...

ART-0380 is under clinical development by Artios Pharma and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase II drugs for Endometrial Cancer have a 22% phase transition ...